Search Results - matthew+gumbleton

1 Results Sort By:
Small molecule inhibition of SHIP1 induces broad activation of natural killer cells
This technology involves methods to activate natural killer (NK) cells by inhibiting the SHIP1 enzyme, offering new therapeutic approaches to treat cancers and infectious diseases. Background: Natural killer (NK) cells play a vital role in the body's innate immune defense, targeting and eliminating tumor cells and infected cells. However, their...
Published: 6/15/2026   |   Updated: 6/15/2026   |   Inventor(s): William Kerr, Matthew Gumbleton
Keywords(s):  
Category(s): Campus > Upstate Medical University, Technology Classifications > Therapeutics and Vaccines